Summary
Opioid agonists selective for µ-, δ-, and κ-receptors are all capable of regulating the stimulated release of noradrenaline from three terminal fields (cortex, hippocampus, and cerebellum) of the noradrenergic projections from locus coeruleus in the guinea pig brain. Intracerebroventricular injections of pertussis toxin abolished the ability of a µ-selective agonist and of a δ-selective agonist to inhibit stimulated noradrenaline release, but left unaffected the concentration-related inhibition of NE release by a κ agonist. Thus, µ- and δ-receptors have been shown to be coupled to their effector systems in these noradrenergic neurons via guanyl nucleotide binding proteins (G proteins) which are sensitive to pertussis toxin, while κ-receptors in the same neurons appear to be coupled through a different mechanism which is significantly less sensitive to pertussis toxin. In contrast to opioid receptor regulation of noradrenaline release in guinea pig hippocampus, µ-, but not δ- or κ-agonists are capable of regulation of stimulated noradrenaline release from rat hippocampus and cortex, and κ-, but not µ- or δ-agonists are capable of inhibiting the stimulated release of dopamine from rat striatum and cortex. Pertussis toxin injections significantly attenuated µ-agonist inhibition of noradrenaline release, but had no effect on the ability of a κ-selective agonist to regulated dopamine release, confirming the insensitivity of the κ-receptor-effector coupling system to pertussis toxin.
Similar content being viewed by others
References
Aghajanian GK, Wang YY (1986) Pertussis toxin blocks the outward currents evoked by opiate and α2-agonists in locus coeruleus neurons. Brain Res 371:390–394
Allgaier C, Feuerstein TJ, Jackisch R, Hertting G (1985) Islet-activating protein (pertussis toxin) diminishes α2-adrenoceptor mediated effects on noradrenaline release. Naunyn-Schmiedeberg's Arch Pharmacol 331:235–239
Allgaier C, Hertting G, Kugelgen OV (1987) The adenosine receptor-mediated inhibition of noradrenaline release possibly involves a N-protein and is increases by α2-autoreceptor blockade. Br J Pharmacol 90:403–412
Aub DL, Frey EA, Sekura RD, Cote TE (1986) Coupling of the thyrotropin-releasing hormone receptor to phospholipase C by a GTP-binding protein distinct from the inhibitory or stimulatory GTP-binding protein. J Biol Chem 261:9333–9340
Blume AJ (1978) Interactions of ligands with the opiate receptors of brain membranes: regulation by ions and nucleotides. Proc Natl Acad Sci USA 75:1713–1717
Burns DL, Hewlett EL, Moss J, Vaughan M (1983) Pertussis toxin inhibits enkephalin stimulation of GTPase of NG108–15 cells. J Biol Chem 258:1435–1438
Clark MJ, Levenson SD, Medzihradsky F (1986) Evidence for coupling of the κ opioid receptor to brain GTPase. Life Sci 39:1721–1727
Gross RA, Mac Donald RL (1987) Dynorphin A selectively reduces a large transient (N-type) calcium current of mouse dorsal root ganglion neurons in cell culture. Proc Natl Acad Sci USA 84:5469–5473
Hagan RM, Hughes IE (1984) Opioid receptor subtypes involved in control of transmitter release in cortex of the brain of the rat. Neuropharmacology 23:491–495
Hescheler J, Rosenthal W, Trautwein W, Schulz G (1987) The GTP-binding protein, G0, regulates neuronal calcium channels. Nature (Lond) 325:443–447
Kurose H, Katada T, Amano T, Ui M (1983) Specific uncoupling by islet-activating protein, pertussis toxin, of negative signal transduction via α-adrenergic, cholinergic, and opiate receptors in neuroblastoma x glioma hybrid cells. J Biol Chem 258:4870–4875
Luparello TJ (1967) Stereotactic Atlas of the guinea pig forebrain. The Williams and Wilkins Co., Baltimore
Milligan G, Gierschiek P, Spiegel AM, Klee WA (1986) The GTP-binding regulatory proteins of neuroblastoma x glioma, NG108–15, and glioma, C6 cells. FEBS Lett 195:225–230
Montel H, Starke K, Weber F (1974) Influence of morphine and naloxone on the release of noradrenaline from rat cortex slices. Naunyn-Schmiedeberg's Arch Pharmacol 283:357–369
Mulder AH, Wardeh G, Hogenboom F, Frankhuyzen AL (1984) κ- and δ-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release. Nature (Lond) 308:278–280
Nakamura S, Tepper JM, Young SJ, Ling N, Groves PM (1982) Noradrenergic terminal excitability: Effects of opioids. Neurosci Lett 30:57–62
North RA, Williams JT, Surprenant A, Christie MJ (1987) µ and δ receptors belong to a family of receptors that are coupled to potassium channels. Proc Natl Acad Sci USA 84:5487–5491
Pellegrino LJ, Pellegrino AS, Cushman AJ (1979) A stereotaxic atlas of the rat brain, 2nd edn. Plenum Press, New York
Puttfarcken PS, Werling LL, Cox BM (1988) Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c membranes: A useful model in the study of tolerance at µ opioid receptors. Mol Pharmacol 33:520–527
Sullivan KA, Miller RT, Masters SB, Beidermann B, Heideman W, Bourne HR (1987) Identification of receptor contact site involved in receptor-G protein coupling. Nature (Lond) 330:758–762
Tucker JF (1984) Effects of pertussis toxin on normorphine-dependence and on acute inhibitory effects of normorphine and clonidine in guinea-pig isolated ileum. Br J Pharmacol 83:326–328
Ungerstedt U (1971) Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol Scand 367:1–48
Werling LL, Brown SR, Cox BM (1984) The sensitivity of opioid receptor types to regulation by sodium and GTP. Neuropeptides 5:137–140
Werling LL, Brown SR, Cox BM (1987) Opioid receptor regulation of the release of norepinephrine in brain. Neuropharmacology 26:987–996
Werling LL, Puttfarcken PS, Cox BM (1988a) Multiple agonist affinity states of opioid receptors: Regulation of binding by guanyl nucleotides in guinea pig cortical, NG108–15, and 7315c cell membranes. Mol Pharmacol 33:423–431
Werling LL, Frattali A, Portoghese PS, Takemori AE, Cox BM (1988b) Kappa receptor regulation of dopamine release from straitum and cortex of rats and guinea pigs. J Pharmacol Exp Ther 246:282–286
Werling LL, McMahon PN, Cox BM (1988c) Selective tolerance at mu and kappa opioid receptors modulating norepinephrine release in guinea pig cortex. J Pharmacol Exp Ther 247:1103–1106
Werling LL, McMahon PN, Portoghese PS, Takemori AE, Cox BM (1989) Selective opioid antagonist effects on opioid inhibition of norepinephrine release in guinea pig cortex. Neuropharm4cology 28:103–107
Author information
Authors and Affiliations
Additional information
This work was supported by a grant from the National Institute on Drug Abuse. The opinions and assertions contained herein are the private ones of the authors and are not to be construed as official or reflecting the views of the Department of Defense or the Uniformed Services University of the Health Sciences. Animals used in this study were acquired and cared for in accordance with the guidelines published in the NIH Guide for the Care and Use of Laboratory Animals (National Institutes of Health Publications No. 85-23 Revised 1985)
Send offprint requests to L. L. Werling at the above address
Rights and permissions
About this article
Cite this article
Werling, L.L., McMahon, P.N. & Cox, B.M. Effects of pertussis toxin on opioid regulation of catecholamine release from rat and guinea pig brain slices. Naunyn-Schmiedeberg's Arch Pharmacol 339, 509–513 (1989). https://doi.org/10.1007/BF00167253
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00167253